Conversely, YTHDF1 gene expression is reported to be significantly upregulated in colorectal cancer, thereby reducing the sensitivity of tumor cells to cisplatin [210], suggesting that YTHDF1 mediates chemoresistance through distinct expression patterns in different cancer types. This evidence concerns the gene YTHDF1 and cancer.